Diederik van Bodegom
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Acute Lymphoblastic Leukemia research, Chronic Lymphocytic Leukemia Research, Genetic and Kidney Cyst Diseases, Hedgehog Signaling Pathway Studies
Most-Cited Works
- → A targeted mutational landscape of angioimmunoblastic T-cell lymphoma(2013)425 cited
- → Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition(2012)162 cited
- → p53 regulates a non-apoptotic death induced by ROS(2013)137 cited
- → Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation(2014)132 cited
- → Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia(2015)121 cited
- → TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling(2014)99 cited
- → BCL2 Suppresses PARP1 Function and Nonapoptotic Cell Death(2012)54 cited
- → Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2(2012)47 cited
- → The Polycystic Kidney Disease-1 Gene Is a Target for p53-mediated Transcriptional Repression(2006)46 cited
- → HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma(2016)42 cited